Drug recall · July 15, 2020
Tecfidera recall
Why: cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tecfidera (dimethyl fumarate) delayed-release capsules, 240 mg, 60-count bottle, Rx only, Manufactured by: Biogen Inc., Cambridge, MA 02142, NDC 64406-006-02
- Lots / codes
Lot # SH0274, Exp 2/2022
- Quantity
- 3,922 bottles
- Company
- Biogen MA Inc., Research Triangle Park, NC
- Distribution
- Product was distributed to wholesalers/distributors in KY, OH & MS.
- Initiated
- June 23, 2020 · Voluntary: Firm initiated
- Classified
- July 9, 2020
- Reported
- July 15, 2020
- Ended
- February 11, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dimethyl fumarate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.